TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,390,966 | -47.5% | 405,618 | +56.0% | 0.02% | -45.9% |
| Q2 2023 | $6,457,183 | +65.2% | 259,951 | 0.0% | 0.04% | +54.2% |
| Q1 2023 | $3,909,663 | -10.1% | 259,951 | -29.3% | 0.02% | -17.2% |
| Q4 2022 | $4,347,206 | +552.7% | 367,473 | +226.7% | 0.03% | +480.0% |
| Q3 2022 | $666,000 | +42.9% | 112,495 | +370.7% | 0.01% | 0.0% |
| Q2 2020 | $466,000 | +86.4% | 23,900 | -5.9% | 0.01% | +66.7% |
| Q1 2020 | $250,000 | -86.7% | 25,401 | -85.0% | 0.00% | -83.3% |
| Q4 2019 | $1,878,000 | +177.8% | 169,200 | +40.5% | 0.02% | +125.0% |
| Q3 2019 | $676,000 | -27.6% | 120,400 | +11.5% | 0.01% | -38.5% |
| Q2 2019 | $934,000 | +166.1% | 108,000 | +304.3% | 0.01% | +116.7% |
| Q2 2018 | $351,000 | – | 26,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |